772 Which factors predict overall survival in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate post-docetaxel?

2016 ◽  
Vol 15 (3) ◽  
pp. e772-e772a
Author(s):  
C. Van Praet ◽  
S. Rottey ◽  
F. Van Hende ◽  
G. Pelgrims ◽  
W. Demey ◽  
...  
2020 ◽  
Vol 3 (1) ◽  
pp. 119-127 ◽  
Author(s):  
Eleni Efstathiou ◽  
Mark Titus ◽  
Sijin Wen ◽  
Patricia Troncoso ◽  
Anh Hoang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document